Medidata’s Patient Experience Recognized as Sustainability Solution by the European Union, Paving the Way for Greener Clinical Trials
16 Janeiro 2025 - 10:00AM
Business Wire
By eliminating over 7.5 million kilometers of
travel, Medidata's Patient Experience is at the forefront of
minimizing carbon emissions in decentralized clinical trials
Medidata, a Dassault Systèmes brand and leading provider of
clinical trial solutions to the life sciences industry, today
announced that Medidata Patient Cloud, a solution driving the
brand’s patient experience, has achieved EU taxonomy certification,
marking a significant advancement in supporting the conduct of
environmentally responsible clinical trials. In 2023, 16% of
Medidata’s revenue aligned with these high environmental standards,
reflecting the brand’s commitment to sustainability. Additionally,
its partnerships and software solutions are helping to foster a
circular approach to clinical trials, focusing on sustainability by
reducing travel, optimizing resources, and producing long-term
value for both patients and the planet.
The EU taxonomy classification system provides a framework to
identify environmentally responsible activities. By reducing
reliance on physical materials and patient travel, Medidata Patient
Cloud eliminated over 7.5 million kilometers of travel across
multiple trials, saving approximately 0.048 tons of CO2 emissions
per patient. To be more specific, one study that leveraged
Medidata’s Patient Cloud saved a sizable 723.65 tons of carbon
while collecting data from 15,076 patients, saving 726 acres of
U.S. forests in one year from carbon sequestration. These metrics
were verified by external, third-party consultants, with the
methodology used adhering to standards set by the ISO 14064-2, ISO
14040/44, and ISO 14067 frameworks.
Patient Cloud features a single portal designed to easily
capture the patient experience in clinical trials regardless of
location. The solution breaks down the barriers associated with
traditional studies, such as travel requirements for patients and
researchers and onsite data collection and monitoring, leading to
better patient engagement while simultaneously reducing carbon
emissions.
"Achieving EU taxonomy certification marks a significant
milestone in Medidata’s commitment to sustainable clinical trials,"
said Matt Noble, senior vice president, head of Patient Cloud,
Medidata. "Decentralized clinical trials remove geographic barriers
for patients, reducing travel and carbon emissions, while improving
engagement and the overall study experience. By bringing research
directly to patients, we’re advancing healthcare and building a
future that is more accessible, sustainable, and responsible to
both people and the planet."
To learn more about Medidata Patient Experience, visit here.
Editor’s note: The methodology utilized complies with the
following ISO standards, which ensure transparency and credibility
in sustainability reporting. ISO 14064-2 provides guidelines for
quantifying and reporting greenhouse gas emissions reductions and
removal enhancements. ISO 14040/44 focuses on life cycle
assessment, detailing principles and frameworks for assessing
environmental impacts associated with a product or service
throughout its life cycle. ISO 14067 specifies principles,
requirements, and guidelines for the quantification and
communication of the carbon footprint of products.
About Medidata
Medidata is powering smarter treatments and healthier people
through digital solutions to support clinical trials. Celebrating
25 years of ground-breaking technological innovation across more
than 35,000 trials and 10 million patients, Medidata offers
industry-leading expertise, analytics-powered insights, and the
largest patient-level historical clinical trial data set in the
world. More than 1 million registered users across approximately
2,300 customers trust Medidata’s seamless, end-to-end platform to
improve patient experiences, accelerate clinical breakthroughs, and
bring therapies to market faster. A Dassault Systèmes brand
(Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered
in New York City and has been recognized as a Leader by Everest
Group and IDC. Discover more at www.medidata.com and follow us
@Medidata.
About Dassault Systèmes
Dassault Systèmes is a catalyst for human progress. Since 1981,
the company has pioneered virtual worlds to improve real life for
consumers, patients and citizens. With Dassault Systèmes’
3DEXPERIENCE platform, 350,000 customers of all sizes, in all
industries, can collaborate, imagine and create sustainable
innovations that drive meaningful impact. For more information,
visit: www.3ds.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250116503803/en/
Medidata PR
Medidata.PR@3ds.com
Analyst Relations
medidata.AR@3ds.com
Big Tree Cloud (NASDAQ:DSY)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Big Tree Cloud (NASDAQ:DSY)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
